Malignant Asbestos Mesothelioma Lung Cancer: News & Information

 
Mesothelioma Information
 
 
 
Search
Custom Search
Mesothelioma Lawsuits
Subscribe via Email

Enter your E-mail address

Previous Post
Archives
Live Traffic
Favorites
Add to Technorati Favorites
Subscribe to me on FriendFeed
Join My Community at MyBloglog!
http://www.wikio.com
My Zimbio
Follow Me
Catch me on Twitter
Find me through Facebook
Reach me at Orkut
Digg Profile
Stumble Me!
MicroRNA-based Molecular Diagnostic Test for Mesothelioma and Lung Cancer
Thursday, January 1, 2009
The recently discovered and naturally occurring microRNAs (miRNAs) act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases.

Rosetta Genomics, a Philadelphia-based developer of microRNA-based molecular diagnostic tests, has developed a comprehensive mesothelioma diagnosis exam that is now commercially available. The test is the third microRNA-based diagnostic test created by the lab and is known as miRview™ meso. miRview™ meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation.
posted by Elena @ 6:07 AM  
2 Comments:

Post a Comment

<< Home
 
 Subscribe via RSS
Add to The Free Dictionary

Add to Plusmo

Subscribe in NewsAlloy

Add to Excite MIX

Add to netomat Hub

Add to fwicki

Add to Webwag

Add to Attensa

Receive IM, Email or Mobile alerts when new content is published on this site.
Forum Discussion
Discussion board for asbestos mesothelioma lung cancer and its treatments
Mesothelioma Treatment
Links
News Feed Widget

Alexa Rank
Powered by
BLOGGER
Copyright © 2009 Malignant Asbestos Mesothelioma Lung Cancer: News & Information. All rights reserved